Janus Henderson Group PLC Avidity Biosciences, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RNA
# of Institutions
246Shares Held
96.8MCall Options Held
198KPut Options Held
286K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$510 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$431 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.81MShares$412 Million6.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$403 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.51MShares$304 Million3.63% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.44B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...